Profil
Stephen M Hahn is the Chief Executive Officer at Nucleus Radiopharma, Inc. since 2025.
Mr. Hahn is also a Director at Ion Beam Applications SA since 2026.
Mr. Hahn completed undergraduate education at William Marsh Rice University and graduate education at Temple University (Pennsylvania).
Postes actifs de Stephen Hahn
| Sociétés | Poste | Début |
|---|---|---|
| ION BEAM APPLICATIONS, SA | Directeur/Membre du Conseil | 16/06/2026 |
Nucleus Radiopharma, Inc.
Nucleus Radiopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a end-to-end contract development and manufacturing organization | Directeur Général | 20/08/2025 |
Formation de Stephen Hahn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Ion Beam Applications SA
Ion Beam Applications SA Medical SpecialtiesHealth Technology Supplies medical, dental and hospital equipment | Health Technology |
Rice University
Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nucleus Radiopharma, Inc.
Nucleus Radiopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a end-to-end contract development and manufacturing organization | Health Technology |
















